1. Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients
   Yuanyuan Sun et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
2. Old wine in new bottles: Drug repurposing in oncology
   Michał Antoszczak et al, 2020, European Journal of Pharmacology CrossRef
3. Overexpression of ubiquitin specific proteases 44 promotes the malignancy of glioma by stabilizing tumor-promoter securin
   Yongxiang Zou et al, 2017, Oncotarget CrossRef
4. Overcoming cancer therapeutic bottleneck by drug repurposing
   Zhe Zhang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
5. Thalidomide suppresses migration and invasion of colorectal cancer cells by inhibiting HOXB7‐mediated activation of the Wnt/β‐catenin signaling pathway
   Liyang Liu et al, 2024, Chemical Biology & Drug Design CrossRef
6. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis
   De-Dong Cao et al, 2017, Oncotarget CrossRef
7. How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
   Alessandro Poggi et al, 2018, Frontiers in Immunology CrossRef
8. Expression and function of Toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis
   Jun Zhang et al, 2019, Molecular Medicine Reports CrossRef
9. Intravesical Thalidomide boosts bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer treatment
   Gabriela R. Passos et al, 2018, Medical Oncology CrossRef
10. A Novel Nanoemulsion Formula for an Improved Delivery of a Thalidomide Analogue to Triple-Negative Breast Cancer; Synthesis, Formulation, Characterization and Molecular Studies
    Noran M Tawfik et al, 2023, International Journal of Nanomedicine CrossRef
11. Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells
    Xin Zhang et al, 2017, Oncology Letters CrossRef